Avapro and Exjade drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Avapro (irbesartan) and Exjade (deferasirox). Common drug interactions include pain among females and vomiting among males.
The phase IV clinical study analyzes what interactions people have when they take Avapro and Exjade. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Avapro?
Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.
What is Exjade?
Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.
35 people who take Avapro and Exjade together, and have interactions are studied.

What are the common drug interactions of Avapro and Exjade, by gender? *:
female:
- Pain
- Renal disorder (kidney disease)
- White blood cell count decreased
- Dizziness
- Arthralgia (joint pain)
- Blood urea increased
- Dry skin
- Dyspepsia (indigestion)
- Dyspnoea (difficult or laboured respiration)
- Erythema (redness of the skin)
male:
- Vomiting
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Skin lesion
- Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
- Swelling face
- Death
- Neutropenia (an abnormally low number of neutrophils)
- Haematocrit decreased
- Haemoglobin decreased
- Hepatomegaly (abnormal enlargement of the liver)
What are the common drug interactions of Avapro and Exjade, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Blood creatinine increased
- Blood urea increased
- Proteinuria (presence of protein in the urine)
- Renal disorder (kidney disease)
- Renal failure (kidney dysfunction)
- Renal failure acute (rapid kidney dysfunction)
40-49:
n/a
50-59:
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Blood bilirubin unconjugated increased
- Blood chloride decreased
- Blood creatinine decreased
- Blood disorder
- Blood lactate dehydrogenase increased
- Blood potassium decreased
- Blood sodium decreased
- C-reactive protein increased
60+:
- Vomiting
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Scab (a hard coating on the skin formed during the wound healing)
- Skin exfoliation (removal of the oldest dead skin cells)
- Skin lesion
- Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
- Swelling face
- Blood glucose increased
What are the existing conditions these people have? *
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 9 people, 25.71%
- High Blood Cholesterol: 6 people, 17.14%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 8.57%
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 5.71%
- Muscle Aches (muscle pain): 2 people, 5.71%
- Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 2 people, 5.71%
- Diabetes: 2 people, 5.71%
- Constipation: 2 people, 5.71%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 5.71%
* Approximation only. Some reports may have incomplete information.
Do you take Avapro and Exjade?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Avapro and Exjade:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Avapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Exjade:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Avapro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Exjade and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on irbesartan and deferasirox (the active ingredients of Avapro and Exjade, respectively), and Avapro and Exjade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Erysipelas and Hyperkalemia - now
- Drug interactions of Milnacipran Hydrochloride and Hydromorphone Hydrochloride - now
- Drug interactions of Hydromorphone Hydrochloride and Mupirocin - now
- Drug interactions of Enzalutamide and Escitalopram - 6 seconds ago
- Could Ascorbate cause Delirium? - 10 seconds ago
- Could Cosentyx cause Respiratory Tract Infection? - 27 seconds ago
- Renal Cancer Metastatic and Swollen Tongue - 30 seconds ago
- Could Zoloft cause Hyperkalemia? - 30 seconds ago
- Could Klor-Con cause Ear Congestion? - 33 seconds ago
- Telmisartan vs. Candesartan Cilexetil, side effect and effectiveness comparison - 34 seconds ago